Hosted on MSN1mon
Penumbra spikes after Stryker- Inari deal
Penumbra (PEN) is “likely to carry the most ... thrombectomy technology for peripheral vascular diseases like DVT and PE,” Jennings, with a Buy recommendation on Stryker (SYK), added.
WTOP News5d
Penumbra: Q4 Earnings Snapshot
ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Penumbra Inc. (PEN) on Tuesday reported fourth-quarter profit of $33.7 million. On a per-share basis, the Alameda, California-based company said ...
Seeking Alpha4d
Penumbra targets 13%-14% revenue growth for 2025 with focus on thrombectomy market expansion
Penumbra closed 2024 on a strong note, driven by robust growth in its U.S. thrombectomy business and the successful introduction of new CAVT products. Despite challenges in the China market and ...